Moleculin Biotech, Inc.

MBRX · NASDAQ
Analyze with AI
Filings30
Total reported value$3.2M
ManagerSharesValue
Change
VANGUARD GROUP INC239.9K$993.3K+46.6%
GEODE CAPITAL MANAGEMENT, LLC208.2K$862.0K+46.5%
HRT FINANCIAL LP115.2K$476.9K+50.0%
LPL Financial LLC58.1K$240.5K+3.3%
IEQ CAPITAL, LLC36.4K$150.5K+50.0%
Wealth Dimensions Group, Ltd.20K$82.8K+50.0%
Rockefeller Capital Management L.P.14.5K$60.1K+50.0%
Cambridge Investment Research Advisors, Inc.12.8K$52.9K0.0%
GOLDMAN SACHS GROUP INC12.8K$52.8K+50.0%
BlackRock, Inc.12.4K$51.3K0.0%
TRUIST FINANCIAL CORP10.5K$43.5K0.0%
Ethos Financial Group, LLC10K$41.5K+50.0%
Moors & Cabot, Inc.10K$41.4K+50.0%
Tower Research Capital LLC (TRC)8.4K$34.7K+34.7%
UBS Group AG4K$16.4K+6,820.3%
Newbridge Financial Services Group, Inc.2.9K$11.9K0.0%
MORGAN STANLEY926$3.8K0.0%
SBI Securities Co., Ltd.746$3.1K0.0%
Bogart Wealth, LLC300$1.2K0.0%
BANK OF AMERICA CORP /DE/266$1.1K+31.1%
ADVISOR GROUP HOLDINGS, INC.43$178.00.0%
CVA Family Office, LLC34$140.80.0%
North Star Investment Management Corp.17$70.40.0%
NBC SECURITIES, INC.14$58.0+50.0%
Stone House Investment Management, LLC0$0.0+100.0%
Atlantic Union Bankshares Corp0$0.0+100.0%
Virtu Financial LLC0$0.0+100.0%
VERUS CAPITAL PARTNERS, LLC0$0.0+100.0%
CITIGROUP INC0$0.0+100.0%
XTX Topco Ltd0$0.0+100.0%